Authors
Chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida.
Shayla Bergmann, MD, is a clinical professor in pediatric hematology at the Medical University of South Carolina.
Arthur L. Jenkins III, MD, FACS, is a board-certified neurosurgeon, an expert in complex spinal neurosurgery, and CEO of Jenkins NeuroSpine.
The PROUD Trial Collaborators are Amy M. Loree, PhD, Center for Health Policy and Health Services Research, Henry Ford Health; Leah K. Hamilton, PhD, Kaiser Permanente Washington Health Research Institute; Julia H. Arnsten, MD, Albert Einstein College of Medicine, Montefiore Medical Center; Mark T. Murphy, MD, MultiCare Health System; José Szapocznik, PhD, Department of Public Health Sciences, University of Miami Miller School of Medicine; Mohammad Zare-Mehrjerdi, MD, Department of Family and Community Medicine, UTHealth Houston McGovern Medical School; Mary Shea, MA, Kaiser Permanente Washington Health Research Institute; and Rebecca Phillips, MA, Kaiser Permanente Washington Health Research Institute.